Type/NN
II/CD
estrogen/NN
binding/NN
sites/NNS
in/IN
human/JJ
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
:/:
variations/NNS
during/IN
the/DT
menstrual/JJ
cycle/NN
./.

We/PRP
have/VBP
previously/RB
reported/VBN
that/IN
human/JJ
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
(/(
PBMC/NNS
)/)
contain/VBP
type/NN
II/CD
estrogen/NN
binding/NN
sites/NNS
(/(
type/NN
II/CD
EBS/NNS
)/)
./.
=====
In/IN
this/DT
study/NN
,/,
the/DT
fluctuations/NNS
of/IN
type/NN
II/CD
EBS/NNS
during/IN
the/DT
menstrual/JJ
cycle/NN
were/VBD
analyzed/VBN
in/IN
6/CD
normally/RB
menstruating/VBG
women/NNS
./.
=====
Approximately/RB
3/CD
times/NNS
higher/JJR
levels/NNS
of/IN
type/NN
II/CD
EBS/NNS
were/VBD
found/VBN
in/IN
the/DT
periovulatory/JJ
period/NN
with/IN
respect/NN
to/TO
both/CC
follicular/JJ
and/CC
luteal/JJ
phases/NNS
./.
=====
In/IN
postmenopausal/JJ
women/NNS
the/DT
mean/NN
type/NN
II/CD
EBS/NNS
levels/NNS
were/VBD
similar/JJ
to/TO
those/DT
observed/VBN
in/IN
the/DT
follicular/JJ
phase/NN
of/IN
the/DT
cycle/NN
./.
=====
However/RB
,/,
in/IN
3/CD
postmenopausal/JJ
patients/NNS
a/DT
short/JJ
course/NN
of/IN
estrogen/NN
or/CC
tamoxifen/NN
resulted/VBD
in/IN
a/DT
marked/JJ
increase/NN
of/IN
type/NN
II/CD
EBS/NNS
levels/NNS
./.
=====
Tamoxifen/NN
was/VBD
also/RB
found/VBN
to/TO
compete/VB
with/IN
17/CD
beta-estradiol/NN
for/IN
type/NN
II/CD
EBS/NNS
in/IN
PBMC/NNS
,/,
although/IN
to/TO
a/DT
lesser/JJR
extent/NN
than/IN
diethylstilbestrol/NN
./.